buy medicine online indiamedicine online

    Gliclazide + Pioglitazone + Metformin

    Information about Gliclazide + Pioglitazone + Metformin

    Gliclazide + pioglitazone + metformin uses

    Gliclazide+Pioglitazone+Metformin is used in the treatment of type 2 diabetes.

    How gliclazide + pioglitazone + metformin works

    This is a combination of three antidiabetic medicines: Gliclazide, Pioglitazone and Metformin. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Gliclazide is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Pioglitazone is a thiazolidinedione which increases insulin sensitivity. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and further increasing the body's sensitivity to insulin.

    Common side effects of gliclazide + pioglitazone + metformin

    Hypoglycemia (low blood sugar level), Nausea, Altered taste, Diarrhoea, Stomach pain, Headache, Edema (swelling), Weight gain, Blurred vision, Bone fracture, Respiratory tract infection

    Available Medicine for Gliclazide + Pioglitazone + Metformin

    • ₹71 to ₹103
      Ipca Laboratories Ltd
      4 variant(s)
    • ₹66 to ₹111
      Micro Labs Ltd
      2 variant(s)
    • ₹77 to ₹92
      Panacea Biotec Ltd
      2 variant(s)
    • ₹76 to ₹116
      Sun Pharmaceutical Industries Ltd
      3 variant(s)
    • ₹96 to ₹115
      Eris Life Sciences Pvt Ltd
      2 variant(s)

    Content on this page was last updated on 13 April, 2018, by Dr. Varun Gupta (MD Pharmacology)